New statistics methods for dose finding studies
Tuesday, April 21, 2015 - 10:30
in Mathematics & Economics
Less than 0.02 per cent of potential active ingredients pass clinical tests and become commercially viable. However, it is possible that some candidates are rejected without good reason, suspects mathematician Prof Dr Holger Dette. Together with his team, he has developed a new calculation method which may facilitate the management of clinical dose finding studies. The report has been published in the Ruhr-Universität's science magazine "RUBIN".